Talaris Therapeutics Inc. (TALS)
NASDAQ: TALS
· Real-Time Price · USD
2.72
-0.02 (-0.73%)
At close: Oct 19, 2023, 10:00 PM
Talaris Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -95.2M | -72.11M | -56.15M | -41.93M | -44.25M | -62.78M | -74.77M | -78.13M | -73.89M | -69.61M | -63.54M | -56.79M | -47.83M | -40.37M | -33.85M | -27.16M |
Depreciation & Amortization | -827K | -839K | -851K | 271K | 900K | 1.45M | 2.02M | 2.31M | 2.16M | 1.8M | 1.39M | 976K | 623K | 560K | 522K | 490K |
Stock-Based Compensation | 9.57M | 7.52M | 5.24M | 4.66M | 5.25M | 7.91M | 10.95M | 12.62M | 11.16M | 9.08M | 7.09M | 5.14M | 3.78M | 3.38M | 2.51M | 1.73M |
Other Working Capital | 485.68K | 485.68K | 485.68K | 67.68K | -4K | 142K | 2.54M | 1.31M | -567K | 1.39M | 792K | 800K | 992K | -939K | -1.63M | 941K |
Other Non-Cash Items | -35.7M | -36.05M | -28.04M | 13.57M | 23.2M | 22.21M | 14.9M | 65K | -1.38M | -370K | n/a | 579K | 1.13M | 1.35M | 1.55M | 1.01M |
Deferred Income Tax | 15.28M | 15.28M | 15.28M | -15.28M | -15.28M | -15.28M | -15.28M | n/a | n/a | n/a | n/a | 109K | 302K | 528K | 528K | 419K |
Change in Working Capital | 2.82M | 2.82M | 2.82M | 1.01M | -980K | 1.04M | 3.31M | 1.66M | 1.1M | 2.29M | 1.53M | 2.88M | 2.31M | -723K | -1.24M | 904K |
Operating Cash Flow | -104.05M | -83.79M | -69.13M | -45.14M | -38.6M | -52.47M | -58.88M | -61.48M | -60.86M | -56.82M | -53.52M | -47.22M | -39.99M | -35.81M | -30.5M | -23.02M |
Capital Expenditures | 516K | 523K | 532K | -221K | -541K | -810K | -1.15M | -2.02M | -3.04M | -3.96M | -4.35M | -3.59M | -2.44M | -1.5M | -1.11M | -1.12M |
Cash Acquisitions | 36.87K | 36.87K | 36.87K | -9.14K | -36.87K | -46.15K | -52.8K | -43.66K | -15.93K | -6.64K | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | -505.17M | -464.71M | -379.55M | -137.41M | -74.63M | -125.62M | -178.23M | -176.87M | -191.58M | -205.68M | -189.02M | -281.56M | -275.88M | -317.9M | -309.98M | -173.43M |
Sales Maturities Of Investments | 304.57M | 247.8M | 136.69M | 134.85M | 111.5M | 171.77M | 231.02M | 241.54M | 250.29M | 257.02M | 236.14M | 207.87M | 181.93M | 117.93M | 94.88M | 62.04M |
Other Investing Acitivies | -36.87K | -36.87K | -36.87K | 9.14K | 36.87K | 46.15K | 52.8K | 43.66K | 15.93K | 6.64K | n/a | n/a | n/a | -1K | -1K | -1K |
Investing Cash Flow | -200.09M | -216.39M | -242.33M | -2.78M | 36.33M | 45.34M | 51.65M | 62.65M | 55.67M | 47.38M | 42.77M | -77.29M | -96.39M | -201.47M | -216.21M | -112.52M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | 5.00 | 5.00 | 5.00 | -5 | -5 | -5 | -5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 161.78M | 161.73M | 161.16M | 136K | 183K | 243K | 316K | 258K | 242K | 594K | -30K | 137.41M | 137.4M | 136.46M | 268.64M | 131.14M |
Financial Cash Flow | 161.78M | 161.73M | 161.16M | 136K | 183K | 183.06K | 183.13K | 46.21K | 242.00 | 594.00 | -30 | 137.41K | 137.4K | -387.01K | 131.24M | 131.12M |
Net Cash Flow | 3.75M | 7.66M | -4.18M | -47.55M | -2.08M | -6.88M | -6.92M | 1.43M | -4.94M | -8.84M | -10.78M | 12.9M | 1.02M | -100.81M | 21.92M | -4.39M |
Free Cash Flow | -103.54M | -83.27M | -68.59M | -45.36M | -39.14M | -53.28M | -60.03M | -63.5M | -63.9M | -60.78M | -57.87M | -50.81M | -42.42M | -37.3M | -31.62M | -24.14M |